drugset / Trial / NCT04038957

A Clinical Study to Investigate the Effect of an Investigational Drug as an Added Medication to an Antipsychotic, in Adults With Schizophrenia, as Measured Positron Emission Tomography (PET) Imaging

NCT04038957

NaSingle-groupOpen-labelTreatment

Summary

A clinical study to investigate the effect of an investigational drug as an added medication to an antipsychotic, in adults with schizophrenia, as measured positron emission tomography (PET) imaging . This study is accepting male and female participants between 18 years old -45 years old who have been diagnosed with schizophrenia. This study will be conducted in 2 locations in the UK. The study will last approximately 14 months.

Timeline

Start
2019-08-07
Primary completion
2023-06-06
Completion
2023-06-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ulotaront Small molecule 50 mg
Subject Ulotaront Small molecule 75 mg

Indications